1
Return

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications

delete2026-06-26
delete0
PRE
AI
T
Tianyi Ma
Q
Quanyin Hu
DOI:10.1016/j.addr.2026.115923delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Lysosome-targeting degraders (LYTADs) are bifunctional molecules that harness lysosomes to degrade pathogenic proteins. This breakthrough technology addresses a gap in cell membrane- and extracellular protein-targeted degradation technologies. Together with proteolysis-targeting chimeras, LYTADs have driven the development and application of targeted protein degradation (TPD) in biomedicine and other fields, making it one of the most prominent chemical biology technologies of the 21st century. Currently, LYTAD technology has been extensively researched and expanded, demonstrating its ability to degrade a variety of pathogenic proteins across cells, tissues, and diseases, and is not limited to TPD. LYTADs are now in the critical stage of translating their concepts into clinically validated drugs. Many emerging limitations and challenges cannot be addressed through structural design and optimization alone. With the increasing demand for accelerated clinical translation, delivery systems are being used to improve the physicochemical properties of LYTAD molecules in both in vivo and in vitro settings. By combining delivery system design strategies with LYTAD design, or by harnessing delivery systems to deliver LYTADs, the targeting capabilities, therapeutic effects, and biosafety of LYTADs can be enhanced. This integration of delivery systems and LYTADs brings new breakthroughs and opportunities to the field of TPD. In this review, we summarize recent advances in LYTAD delivery systems, focusing on design strategies and biomedical applications. We will also discuss the current challenges and envision future development opportunities of this technology in the biomedical field.

Journal

Advanced Drug Delivery Reviews cover
Advanced Drug Delivery Reviews
IF:
17.6
Papers:
4.5K
Citations:
5.1W

Organization

U
university of wisconsin-madison
Scholars:
2.9K
Papers: 1.2K
Citations: 2
Cited Papers

Cited Papers

Citing Papers

Citing Papers